These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1796924

  • 1. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
    Yamaji Y, Omata T, Abe T, Yoshida A, Ueki S, Aita H, Morita H, Chaki K, Segawa Y, Kurimoto T.
    Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
    [Abstract] [Full Text] [Related]

  • 2. Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.
    Segawa Y, Takei M, Omata T, Tsuzuike N, Yamaji Y, Kurimoto T, Ozeki M, Tagashira E.
    Arzneimittelforschung; 1991 Sep; 41(9):950-3. PubMed ID: 1796923
    [Abstract] [Full Text] [Related]

  • 3. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D, Agut J, Márquez M, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [Abstract] [Full Text] [Related]

  • 4. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM, Evans DC, Warrick MW, Pioch RP.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [Abstract] [Full Text] [Related]

  • 5. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
    Nwokolo CU, Smith JT, Gavey C, Sawyerr A, Pounder RE.
    Aliment Pharmacol Ther; 1990 Nov; 4 Suppl 1():29-45. PubMed ID: 1983345
    [Abstract] [Full Text] [Related]

  • 6. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG, Gottlieb WR, Walter TA, Dreyer M, Müller P, Simon B, Keohane P.
    Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
    Romero A, Gómez F, Villamayor F, Ballesta A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
    [Abstract] [Full Text] [Related]

  • 8. The effect of subchronic administration of 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a novel acid pump antagonist, on gastric acid secretion and gastrin levels in rats.
    Ito K, Kinoshita K, Tomizawa A, Morikawa-Inomata Y, Inaba F, Fujita Y, Tabata K, Shibakawa N.
    J Pharmacol Exp Ther; 2008 Jul; 326(1):163-70. PubMed ID: 18411413
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Localization of 14C-nizatidine in the gastric wall of rats.
    Sano H, Mera Y, Arai K, Suzuki M, Sato H, Matsuda K.
    Arzneimittelforschung; 1991 Sep; 41(9):958-61. PubMed ID: 1796925
    [Abstract] [Full Text] [Related]

  • 11. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
    Ueki S, Seiki M, Yoneta T, Aita H, Chaki K, Hori Y, Morita H, Tagashira E, Itoh Z.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
    [Abstract] [Full Text] [Related]

  • 12. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T, Hirata W, Higichi S.
    Int J Clin Pharmacol Res; 2002 Jan; 22(2):29-35. PubMed ID: 12503773
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
    Jensen RT, Collen MJ, McArthur KE, Howard JM, Maton PN, Cherner JA, Gardner JD.
    Am J Med; 1984 Nov 19; 77(5B):90-105. PubMed ID: 6150641
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
    Itoh H, Naito T, Takeyama M.
    J Pharm Pharmacol; 2002 Nov 19; 54(11):1559-63. PubMed ID: 12495560
    [Abstract] [Full Text] [Related]

  • 16. The influence of prolonged cimetidine administration on serum gastrin levels and gastric acid secretion in rats.
    Kohút A, Mahel'ová O.
    Physiol Res; 1992 Nov 19; 41(6):467-9. PubMed ID: 1299331
    [Abstract] [Full Text] [Related]

  • 17. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB, Tobia AJ, Shriver DA.
    J Pharmacol Exp Ther; 1987 Aug 19; 242(2):437-42. PubMed ID: 2886642
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J, Kunert H, Ottenjann R.
    Scand J Gastroenterol Suppl; 1981 Jun 19; 69():61-5. PubMed ID: 6119784
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB, Scott CK, Shriver DA.
    J Pharmacol Exp Ther; 1986 May 19; 237(2):404-10. PubMed ID: 2871172
    [Abstract] [Full Text] [Related]

  • 20. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
    Fullarton GM, Macdonald AM, McColl KE.
    Aliment Pharmacol Ther; 1991 Aug 19; 5(4):391-8. PubMed ID: 1685675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.